John Somberg MD
Professor Emeritus of Medicine
Cardiology & Pharmacology
Rush University
USA
Biography
Dr. Somberg was born in NYC, graduated NY University (BA), NY Medical College in 1974 with an MD and completed his Cardiology Fellowship at Harvard Medical School, Peter Bent Brigham Hospital in 1978. He trained as a research cardiologist, cellular and clinical electrophysiologist. He established in Cardiac Arrhythmia Service at Albert Einstein College of Medicine in New York, was the Chief of Cardiology at the Chicago Medical School and then became Professor of Medicine and Chief the Division of Clinical Pharmacology at Rush University in Chicago. Dr. Somberg founded the Master's Program in Clinical Research at Rush University, teaching and directing the program for the past 21 years. He was an established investigator for the American Heart Association and been a career clinical investigator, serving as a PI in over 100 Phase I, II, or Ill clinical trials. He has founded and co-organized a course on CV drug development with the Cardio-Renal Division of FDA for 20 years.
Dr. Somberg has published over 250 peer reviewed publications. He was Editor of the Journal of Clinical Pharmacology for 10 years and then was founding Editor of the American Journal of Therapeutics for 20 years, published by Lippincott, Williams & Wilkins, as well as Section Editor for CV Therapeutics for the journal Cardiology. He is a member of the editorial Board of the Am J Cardiology. He has been instrumental in obtaining 2 NDA's, one ANDA and 2 Orphan Drug Designations. Dr. Somberg holds 14 patents.
Dr. Somberg joins the Editorial Board of Cardiology Research as Editor-in-Chief, hoping to enhance the dissemination of translational cardiovascular research and provide a forum for the research of young investigators.
https://profiles.rush.edu/display/204661
User
|
MOST READ |
(For the last 6-month published articles)
|
Thanks to Reviewers 2023 |
|
|
|
QUICK LINKS |
|
|
|
|
|
|
Submit Manuscript |
|
|
Editorial Board |
|
|
|
|
|
|
|
|
|
|
|
Conflict of Interest |
|
|
|
|
|
|
|
|
|
|
ARTICLE STATISTICS |
|
Submission to First Decision |
|
26 Days |
|
Acceptance Rate |
|
31% |
|
Acceptance to Publication |
|
32 Days |
|
*Average article statistics from the last 12 months data |
|
COVID-19 RESEARCH |
|
The COVID-19 outbreak presents the unprecedented challenge for world public and medical practitioners and health care providers, the post COVID-19 condition (or long COVID) includes long term symptoms which may persist for months or years after SARS-CoV-2 infection. We will consider submissions related to all aspects of COVID-19 and Long COVID, and process the manuscripts in priority. |